Donenko F V, Kabieva A O, Borovkova N B, Moroz L V
Biull Eksp Biol Med. 1991 Aug;112(8):188-90.
We have studied by uridine short term test the level of resistance of murine leukemia cell lines P 388/Dx and ELD/Dx carcinoma cells with induced resistance to doxorubicin, P 388/Fp + Dx cells with induced resistance to combination of finoptOFF++ and doxorubicin in vivo. It was shown that the level of resistance was 6 fold for P 388/Dx cells, 4.5 fold for ELD/Dx cells and 2 fold for P 388/Fp + Dx cells. It was shown that the P 388/Dx cells and P 388/Fr + Dx cells had a 3.5 and 4.4 fold increase level of glutathione-S-transferase activity than P 388 cells. No increase in the activity of glutathione-S-transferase was detected in ELD/Dx cells. We conclude that increase of cellular glutathione-S-transferase activity is not associated with the development of resistance to doxorubicin.
我们通过尿苷短期试验研究了小鼠白血病细胞系P 388/Dx和对阿霉素产生诱导抗性的ELD/Dx癌细胞、以及在体内对非诺贝特和阿霉素联合用药产生诱导抗性的P 388/Fp + Dx细胞的耐药水平。结果表明,P 388/Dx细胞的耐药水平为6倍,ELD/Dx细胞为4.5倍,P 388/Fp + Dx细胞为2倍。结果还表明,P 388/Dx细胞和P 388/Fr + Dx细胞的谷胱甘肽-S-转移酶活性水平比P 388细胞分别高3.5倍和4.4倍。在ELD/Dx细胞中未检测到谷胱甘肽-S-转移酶活性增加。我们得出结论,细胞谷胱甘肽-S-转移酶活性的增加与对阿霉素耐药性的产生无关。